Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Activin A Receptor Type IB/ALK-4 anticorps (AA 134-164)

ACVR1B Reactivité: Humain, Souris WB, FACS Hôte: Lapin Polyclonal RB03514 unconjugated
N° du produit ABIN2841926
  • Antigène Voir toutes Activin A Receptor Type IB/ALK-4 (ACVR1B) Anticorps
    Activin A Receptor Type IB/ALK-4 (ACVR1B) (Activin A Receptor, Type IB (ACVR1B))
    Épitope
    • 15
    • 9
    • 7
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 134-164
    Reactivité
    • 48
    • 39
    • 28
    • 1
    Humain, Souris
    Hôte
    • 58
    • 13
    • 3
    • 2
    Lapin
    Clonalité
    • 62
    • 14
    Polyclonal
    Conjugué
    • 34
    • 12
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Activin A Receptor Type IB/ALK-4 est non-conjugé
    Application
    • 49
    • 36
    • 13
    • 13
    • 12
    • 10
    • 8
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS)
    Homologie
    Rat
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This Activin A Receptor Type IB (ACVR1B) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 134-164 amino acids from the Central region of human Activin A Receptor Type IB (ACVR1B).
    Clone
    RB03514
    Isotype
    Ig Fraction
    Top Product
    Discover our top product ACVR1B Anticorps primaire
  • Indications d'application
    WB: 1:1000. FC: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Antigène
    Activin A Receptor Type IB/ALK-4 (ACVR1B) (Activin A Receptor, Type IB (ACVR1B))
    Autre désignation
    Activin A Receptor Type IB (ACVR1B) (ACVR1B Produits)
    Synonymes
    anticorps ACVR1B, anticorps alk4, anticorps skr2, anticorps alk-4, anticorps xalk4, anticorps actrib, anticorps acvrlk4, anticorps DKFZp469A1614, anticorps 6820432J04, anticorps ActR-IB, anticorps ActRIB, anticorps Acvrlk4, anticorps Alk4, anticorps SKR2, anticorps ACTRIB, anticorps ACVRLK4, anticorps ALK4, anticorps Skr2, anticorps axis, anticorps taram-a, anticorps tarama, anticorps wu:fb75f01, anticorps activin A receptor type 1B, anticorps Activin receptor type-1B, anticorps activin A receptor, type IB, anticorps activin A receptor, type 1B, anticorps activin A receptor type 1Ba, anticorps ACVR1B, anticorps acvr1b, anticorps acv1b, anticorps Acvr1b, anticorps acvr1ba
    Sujet
    Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with a cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. The gene for ACVR1B (activin A type IB receptor) is composed of 11 exons. Alternative splicing and alternative polyadenylation result in 3 fully described transcript variants. The mRNA expression of variants 1, 2, and 3 is confirmed, and a potential fourth variant contains an alternative exon 8 and lacks exons 9 through 11, but its mRNA expression has not been confirmed.
    Poids moléculaire
    56807
    ID gène
    91
    NCBI Accession
    NP_004293, NP_064732, NP_064733
    UniProt
    P36896
Vous êtes ici:
Support technique